Symptomatic Cervical Disc Disease
8
0
2
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
12.5%
1 terminated out of 8 trials
75.0%
-11.5% vs benchmark
13%
1 trials in Phase 3/4
100%
3 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Retrospective Analysis of Patients Implanted With 2 Levels of Prodisc® C Vivo Devices
2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C
Exploratory Study of 3D Printed Biodegradable Cervical Interbody Fusion Cage
Retrospective Study With Patients Treated With STALIF® C or M and Ti or FLX Implants for 1 and 2 Levels
Novum Vitrium® Cervical Cage in Anterior Cervical Discectomy and Fusion
Safety and Efficacy Study Comparing ProDisc-C to ACDF Surgery to Treat SCDD
SECURE®-C Cervical Artificial Disc Clinical Study/ SECURE-C Cervical Artificial Disc Postmarket Approval Study
Performance of the Hedrocel(R) Cervical Fusion Device